title: Secondary cutaneous aspergillosis disseminated from the lungs of a patient with asthma on 1 month steroid treatment.
abstract: Cutaneous aspergillosis is very rare and occurs predominantly in transplant patients. Here, we report a 55-year-old female who underwent steroid treatment for 1 month and developed secondary cutaneous aspergillosis from pulmonary aspergillosis due to Aspergillus fumigatus.
authors.affiliation: Department of Emergency Medicine, Chung-Ang University Yong-San Hospital, Seoul 140-757, South Korea.
authors.forename: Chan Woong
authors.initials: CW
authors.lastname: Kim
authors.forename: Jae Seung
authors.initials: JS
authors.lastname: Seo
authors.forename: Mi-Kyung
authors.initials: MK
authors.lastname: Kim
authors.forename: Eun Ju
authors.initials: EJ
authors.lastname: Jun
authors.forename: Jae Chol
authors.initials: JC
authors.lastname: Choi
authors.forename: Byoung Whui
authors.initials: BW
authors.lastname: Choi
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000627:therapeutic use; D001232:Aspergillus fumigatus / Q000302:isolation & purification*; D001249:Asthma / Q000188:drug therapy / Q000382:microbiology*; D003881:Dermatomycoses / Q000188:drug therapy / Q000382:microbiology* / Q000473:pathology; D005260:Female; D006801:Humans; D008775:Methylprednisolone / Q000627:therapeutic use*; D008875:Middle Aged; D055732:Pulmonary Aspergillosis / Q000188:drug therapy / Q000382:microbiology*
chemical_list: D000893:Anti-Inflammatory Agents; D000935:Antifungal Agents; D008775:Methylprednisolone